Monte Rosa Therapeutics, Inc. GLUE Income Tax
Income Tax at other companies
Other financials
Where this comes from
Reported directly by Monte Rosa Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The official record: Monte Rosa Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Monte Rosa Therapeutics, Inc.'s income tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Monte Rosa Therapeutics, Inc.'s income tax?
- Monte Rosa Therapeutics, Inc. (GLUE) reported income tax of $52K in Q1 2026.
- How has Monte Rosa Therapeutics, Inc.'s income tax changed year-over-year?
- Monte Rosa Therapeutics, Inc.'s income tax decreased by 93.7% year-over-year, from $822K to $52K.
- What does income tax mean?
- Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.